Request a copy of the file
Enter the following information to request a copy for the following item: 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
Requesting the following file: 1-s2.0-S0140673613610946-main.pdf